Meeting
2019 ASCO Annual Meeting
Genomic somatic alterations of human epidermal growth factor-2 (HER2) gene: A pan-cancer analysis.
Authors
Xinhua Zhu
Nanjing Drum Tower Hospital,The Affiliated Hospital of Nanjing University Medical School, Nanjing, China
Xinhua Zhu , Yong Zhou , Yuzi Zhang , Shangli Cai
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics and Tumor Biology (Nonimmuno)
Track
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Sub Track
Other Developmental Therapeutics
Citation
J Clin Oncol 37, 2019 (suppl; abstr 3112)
DOI
10.1200/JCO.2019.37.15_suppl.3112
Abstract #
3112
Poster Bd #
104
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Liquid biopsy identification of ERBB2 amplified and HER2 expressing metastatic breast cancer: Comparison and combination of cell and cell-free platforms.
First Author: Giuseppe Di Caro
Poster
2019 ASCO Annual Meeting
Association of HER2 alterations and ESR1 mutations in cell-free DNA (cfDNA) with circulating tumor cells (CTCs), multiple metastasis, and prognosis in stage III/IV breast cancer (BCa).
First Author: Qiang Zhang
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Comprehensive clinico-molecular profile and efficacy of anti-HER2 therapy for HER2-amplified biliary tract cancer.
First Author: Kanae Inoue
Poster
2022 ASCO Annual Meeting
Circulating tumor DNA (ctDNA) in HER2 exon 20 insertion mutations and responses in NSCLC HER2 exon 20 insertion treated with poziotinib.
First Author: Arunthi Thiagalingam